Market cap
$279 Mln
Recently Viewed
Clear AllMarket cap
$279 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$8 Mln
ROE
0 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
0
Debt to Equity
0
Book Value
$--
EPS
$0.3
Face value
--
Shares outstanding
0
CFO
$--
EBITDA
$--
Net Profit
$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Biotech Acquisition Co (BIOTU)
| 1.1 | -0.1 | 1.5 | 1.7 | -- | -- | -- |
|
BSE Sensex*
| -8.7 | 2.7 | -5.2 | -2.4 | 8.6 | 9.8 | 11.5 |
|
Company
|
2022
|
|---|---|
|
Biotech Acquisition Co (BIOTU)
| -0.9 |
|
BSE Sensex
| 4.4 |
|
BSE Sensex
| 4.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was... incorporated in 2020 and is based in New York, New York. Read more
Chairman & CEO
Dr. Michael Shleifer Ph.D.
Chairman & CEO
Dr. Michael Shleifer Ph.D.
Headquarters
New York, NY
Website
--
Our rating system has guided millions of investors in the past 20 years.
The share price of Biotech Acquisition Co (BIOTU) is $10.14 (NASDAQ) as of 10-Feb-2023 09:30 EDT. Biotech Acquisition Co (BIOTU) has given a return of 1.65% in the last 1 years.
Since, TTM earnings of Biotech Acquisition Co (BIOTU) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
-42.39
|
-10,776,990.74
|
|
2020
|
--
|
--
|
|
2021
|
-42.39
|
-10,776,990.74
|
|
2020
|
--
|
--
|
The 52-week high and low of Biotech Acquisition Co (BIOTU) are Rs -- and Rs -- as of 27-Apr-2026.
Biotech Acquisition Co (BIOTU) has a market capitalisation of $ 279 Mln as on 14-Feb-2023. As per SEBI classification, it is a company.
Before investing in Biotech Acquisition Co (BIOTU), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.